Barbados vs Jordan: Access to anti-retroviral drugs, female
Barbados
67.0%
in 2024
Jordan
67.0%
in 2024
Barbados rank
88th
Jordan rank
88th
Access to anti-retroviral drugs, female over time
- Barbados
- Jordan
How they compare
Barbados currently reports 67.0% against 67.0% in Jordan, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Jordan ahead.
Barbados ranks 88th and Jordan ranks 88th of 141 countries.
Barbados has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Barbados | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.4% | 14.0% | 6.4% | Barbados |
| 2010s | 51.6% | 40.1% | 11.5% | Barbados |
| 2020s | 65.8% | 59.6% | 6.2% | Barbados |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Barbados or Jordan?
- Barbados, at 67.0% against 67.0% in Jordan as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Barbados and Jordan?
- 0.0%, with Barbados ahead.
- How many years of comparable data are there for Barbados and Jordan?
- 25 years are reported by both, from 2000 to 2024.
- How do Barbados and Jordan rank globally for access to anti-retroviral drugs, female?
- Barbados ranks 88th and Jordan ranks 88th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.